MedTrace Logo

Factors Related to Participation in Cardiac Rehabilitation in Patients With Acute Coronary Syndrome

NCT05551429 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2024-01-22

No results posted yet for this study

Summary

Acute coronary syndrome (ACS) is one of the most important causes of mortality and morbidity all over the world. Cardiac rehabilitation (CR) is a crucial part of secondary prevention and optimal care of patients with ACS. However, the participation rate in CR after ACS is far from expected. In our study, we will aim to examine the rate of participation in cardiac rehabilitation and the factors affecting it in patients followed up for acute coronary syndrome in the coronary intensive care unit of our hospital. Our main hypothesis is that the lower rate of participation in cardiac rehabilitation in patients with acute coronary syndrome is associated with one or more of that older age, female gender, multimorbidity, poor functional capacity, lower health literacy level or quality of life levels.

Conditions

Interventions

BEHAVIORAL

Invitation to the CR

1. Oral and written information emphasise the benefits of cardiac rehabilitation in terms of treatment of heart diseases, increasing functional capacity, reducing morbidity and mortality, and enhancing secondary prevention. 2. Introducing the scope and method of administration of CR to patients. 3. Setting up the appointment for the initial CR session four weeks later.

Sponsors & Collaborators

  • Gazi University

    lead OTHER

Principal Investigators

  • Nesrin Demirsoy, MD · Gazi University Faculty of Medicine

  • Levent Karataş, MD · Gazi University Faculty of Medicine

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-22
Primary Completion
2023-12-11
Completion
2024-01-12

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05551429 on ClinicalTrials.gov